Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bri-Chem Corp Announces Normal Course Issuer Bid


Thursday, 13 Dec 2012 12:49am EST 

Bri-Chem Corp announced that Bri-Chem has received acceptance from the Toronto Stock Exchange (TSX) in respect of its intention to make a Normal Course Issuer Bid (the "Bid"). The Bid will consist of the acquisition by Bri-Chem of up to 1,103,327 common shares of its capital stock, representing 10% of the public float of 11,033,274 common shares on the proposed date of commencement of the Bid. There are currently 17,366,461 common shares of Bri-Chem issued and outstanding. The Bid is to commence on December 17, 2012, and will terminate on December 16, 2013 or earlier if the number of shares sought in the Bid have been obtained. Bri-Chem reserves the right to terminate the Bid earlier if it feels it is appropriate to do so. All shares acquired under the Bid will be returned to treasury for cancellation. Except for block purchases permitted under the rules and policies of the TSX, the number of Common Shares to be purchased per day will not exceed 3,176, or approximately 25% of the average daily trading volume for the six full calendar months prior to November 30, 2012. 

Company Quote

1.55
-0.03 -1.90%
11 Jul 2014